| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > RSS > The Power of RSS Feeds |
|
Main Subject - The Power of RSS Feeds
Real Simple Syndication or RSS is the powerful web tool of the so-called ‘Web 2.0’ revolution that all Internet marketers a According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product nd Webmasters should be using right now.
RSS and Blogs are revolutionising the distribution of information to consumers, w ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in hether it is HTML, Flash or streaming video. This distribution channel provides a fantastic opportunity for marketers to co lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. nnect directly and build bridges of trust and loyalty with their audience. Many attribute the success of blogs to the tech here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe nologies of RSS and Atom which enables subscribers to receive constantly updating feeds piped to their desktops via RSS rea d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ders, websites or applications. This form of distribution has an advantage over newsletters since it is not blocked by spam ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc filters or lost in a sea of junk. The use of RSS, mostly used today by the web savvy and businesses, is about to hot up w easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ith the new update of Internet Explorer 7 and Microsoft’s new operating system, Vista. IE7 will alert readers when RSS feed nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically s are available and automate the subscription process, as Safari and Firefox do now. Microsoft’s endorsement of RSS could m and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ake it a mass-market technology within a few years, making feed subscriptions as relied on as search engines. A business e ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi fectively using RSS can bring new site visitors, increase search engine positioning and generate product interest. As consu ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a mers become comfortable signing up to feeds from blog and news services, they are more likely to be comfortable with buying dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod from these sources as well. The benefit to the consumer is that they can opt-in to their content of interest, thereby tot cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ally controlling the flow of information that they receive. If the quality of the feeds decline they can simply remove it a tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen nd no longer receive content from that source. Although RSS has been around for several years, it is still in the nursery t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel phase, so business and commerce concepts, such as advertising inserted in RSS feeds or charging for subscriptions are just ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust now starting to appear. Google and Yahoo are in the testing phase of pushing advertising through RSS that has excited marke y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ting people, but has horrified RSS purists, who feel that adverts clogging up these distribution channels are not the way t . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de o go. Wherever the dust settles, consumer expectation will drive businesses that are slow to adopt. It is certain that RSS elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip will become a standard, like email addresses and websites are now a "must" for businesses. RSS feeds will join their ranks tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Layoffs, Redundancy, Survival Guide Where, Oh Where Should I Go to Network?
|